Welcome to LookChem.com Sign In|Join Free

CAS

  • or

64439-81-2

Post Buying Request

64439-81-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64439-81-2 Usage

Description

10-Hydroxycamptothecin is a naturally occurring alkaloid compound derived from the Camptotheca acuminata tree. It possesses a unique chemical structure with a lactone ring and a hydroxyl group at the 10th position, which contributes to its potent biological activity. 10-Hydroxycamptothecin has garnered significant attention in the field of cancer research and treatment due to its ability to inhibit topoisomerase enzymes, essential for DNA replication and transcription.

Uses

Used in Pharmaceutical Industry:
10-Hydroxycamptothecin is used as a therapeutic agent for the treatment of various types of cancer, including liver, stomach, neck, and leukemia. Its mechanism of action involves the inhibition of topoisomerase enzymes, which are crucial for DNA replication and transcription. By targeting these enzymes, 10-Hydroxycamptothecin can effectively halt cancer cell growth and induce cell death.
Used in Cancer Research:
In addition to its clinical applications, 10-Hydroxycamptothecin is also used as a valuable research tool in cancer biology. Its potent topoisomerase inhibitory activity allows scientists to study the molecular mechanisms underlying the action of this enzyme family and their role in cancer development and progression. This knowledge can be instrumental in the development of novel anticancer drugs and therapeutic strategies.
Used in Drug Development:
10-Hydroxycamptothecin serves as a lead compound in the development of new anticancer drugs. Its unique chemical structure and biological activity have inspired the synthesis of various analogs and derivatives with improved pharmacological properties, such as enhanced stability, solubility, and bioavailability. These modified compounds can potentially offer better therapeutic efficacy and reduced side effects compared to the parent compound.

Check Digit Verification of cas no

The CAS Registry Mumber 64439-81-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,4,3 and 9 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 64439-81:
(7*6)+(6*4)+(5*4)+(4*3)+(3*9)+(2*8)+(1*1)=142
142 % 10 = 2
So 64439-81-2 is a valid CAS Registry Number.
InChI:InChI=1/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1

64439-81-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 10-Hydroxycamptothecin

1.2 Other means of identification

Product number -
Other names 64439-81-2

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64439-81-2 SDS

64439-81-2Relevant articles and documents

Multi-gram scale synthesis of a bleomycin (BLM) carbohydrate moiety: exploring the antitumor beneficial effect of BLM disaccharide attached to 10-hydroxycamptothecine (10-HCPT)

Li, MaoLin,Huang, Weiping,Jiang, Zhilin,Shi, Yonghui,Yuan, Sisi,Fu, Kaishuo,Chen, YongJun,Zhou, Li,Zhou, Wen

, p. 6010 - 6020 (2019/04/17)

The “tumor-seeking” role of bleomycin (BLM) disaccharide has been demonstrated to serve as a promising tool for cancer diagnosis and a potential ligand for targeted therapy. However, these practical applications are often hampered by the lack of BLM disaccharide. Herein, an efficient multi-gram synthesis of peracetylated BLM disaccharide 20 is achieved by a TMSOTF-mediated glycosidation coupling manner in 43.6% overall yield in terms of benzyl galactoside. The critical innovation of the synthetic strategy is that inexpensive benzyl galactoside was first adopted to prepare an l-gulose subunit 3 as a glycosyl acceptor, with a much shorter route in 73.0% yield, and a 3-O-carbamoyl-mannose donor 4 was achieved in 47.2% yield by lowering the amount of dibutyltin oxide, and merging aminolysis and selective deacetylation into a one-pot reaction. Next, the incorporation of BLM disaccharide into 10-hydroxycamptothecin (10-HCPT), a non-specific model compound, to form conjugate 1 could significantly improve the antitumor activity and display obvious selectivity toward cancerous and normal cells in comparison with 10-HCPT. Moreover, BLM disaccharide itself was non-cytotoxic, clearly indicating the importance and potential of BLM disaccharide in solving the targeted antitumor therapy of cytotoxic drugs.

Short protecting group-free syntheses of camptothecin and 10-hydroxycamptothecin using cascade methodologies

Xu, Peng,Chen, Dong-Sheng,Xi, Jie,Yao, Zhu-Jun

supporting information, p. 976 - 981 (2015/04/14)

A convergent protecting group-free total synthesis route of camptothecin and 10-hydroxycamptothecin has been developed in this work. Cascade oxidation of 3-(hydroxymethyl)furan-2(5 H)-one and in situ intermolecular oxa Diels-Alder reaction with vinyl ether was developed and applied to construct the E-ring, and TMSCl-promoted cascade closure of the D-ring delivered the whole skeleton of the alkaloids in the total synthesis. The new short syntheses were advantageous with regard to step economy, low cost, easily available starting materials and reagents, and convenient operations.

Synthesis of 10-hydroxycamptothecin: Evaluation of new moderators for the chemoselective reduction of camptothecin

Sekhar,Anjaneyulu, Yerramilli,Acharyulu, V.R.Palle

experimental part, p. 2828 - 2834 (2011/08/22)

10-Hydroxycamptothecin is prepared by chemoselective catalytic hydrogenation of the B-ring of camptothecin over PtO2 with sulfur moderators followed by oxidation using iodobenzenediacetate. New moderators (viz. thioanisole, dimethyl sulfide, diphenyl sulfide, 2-mercapto ethanol), which moderate the hydrogenation of the B- ring of camptothecin, are being explored. Dr. Reddy's Laboratories Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 64439-81-2